Researchers assessed the association of KRAS mutations in metastatic PDAC with the clinical outcomes and responses to first-line chemotherapy regimens.

Findings from a multi-institutional, international study have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk.

Life without a pancreas involves treatments to replace organ function. Learn how different surgical techniques affect overall ...

U.S. Surgeon General Vivek Murthy wants Americans to know that drinking is a preventable risk factor for cancer, and he ...